Trial Profile
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 26 Jul 2012 Results published in the International Journal of Cardiology.
- 25 Oct 2010 New trial record